Liver regeneration .8. Liver regeneration versus direct hyperplasia

被引:152
作者
Columbano, A [1 ]
Shinozuka, H [1 ]
机构
[1] UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261
关键词
D O I
10.1096/fasebj.10.10.8751714
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this, the penultimate article to appear in the series on liver regeneration, Columbano and Shinozuka review the role of primary mitogens as inducers of hepatic growth without cell. loss. Cell proliferation by direct hyperplasia in the absence of compensatory regeneration represents another unique ability of hepatic cells to proliferate. Throughout the series we have dealt primarily with liver regeneration after two-thirds partial hepatectomy or chemical toxicity. We are now introduced to a type of hepatocyte proliferation that does not necessarily require expression of certain immediate early genes or growth factors or even exhibits the same patterns of signal transduction associated with compensatory hyperplasia. The mechanisms involved in transition through the G1 phase of the cell cycle are quite different for the two types of liver regeneration. However, once the hepatocyte is committed to replication, progression through the cell cycle appears to be the same for both types of growth. The characteristics of mitogen-induced direct hyperplasia also appear to depend on the type of mitogen involved. For example, the pattern of ploidy, the perturbation in cytokinesis, and the incidence of multinucleate cells are very different in direct hyperplasia induced by lead nitrate vs. that induced by the peroxisome proliferator nafenopin. However, one common characteristic remains intact: as soon as the mitogenic stimulus is withdrawn, liver mass and DNA content return to their original values, regressing through what appears to be the well-controlled process of apoptosis. In liver regeneration by direct hyperplasia, we become aware of a host of new players, including nuclear receptors for peroxisome proliferators such as clofibrate and the retinoid X receptor for 9-cis retinoic acid. We are also reintroduced to a set of old players including nonparenchymal cells and TNF-alpha. If it begins to seem logical, try to explain why direct hyperplasia is far less effective in initiation of chemical hepatocarcinogenesis than compensatory regeneration. The hepatic cell is truly a remarkable entity, with its myriad of ways to replicate, regress, and remain quiescent. Just when the subject of liver regeneration was beginning to make sense!.
引用
收藏
页码:1118 / 1128
页数:11
相关论文
共 88 条
  • [1] ANTIBODIES TO TUMOR-NECROSIS-FACTOR-ALPHA INHIBIT LIVER-REGENERATION AFTER PARTIAL-HEPATECTOMY
    AKERMAN, P
    COTE, P
    YANG, SQ
    MCCLAIN, C
    NELSON, S
    BAGBY, GJ
    DIEHL, AM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (04): : G579 - G585
  • [2] PPAR-RXR HETERODIMER ACTIVATES A PEROXISOME PROLIFERATOR RESPONSE ELEMENT UPSTREAM OF THE BIFUNCTIONAL ENZYME GENE
    BARDOT, O
    ALDRIDGE, TC
    LATRUFFE, N
    GREEN, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (01) : 37 - 45
  • [3] BEYER HS, 1993, BIOCHEM MOL BIOL INT, V29, P1
  • [4] BEYER HS, 1990, BIOCHEM INT, V22, P405
  • [5] REGENERATION OF MAMMALIAN LIVER
    BUCHER, NLR
    [J]. INTERNATIONAL REVIEW OF CYTOLOGY-A SURVEY OF CELL BIOLOGY, 1963, 15 : 245 - 300
  • [6] CONTROLLED DEATH (APOPTOSIS) OF NORMAL AND PUTATIVE PRENEOPLASTIC CELLS IN RAT-LIVER FOLLOWING WITHDRAWAL OF TUMOR PROMOTERS
    BURSCH, W
    LAUER, B
    TIMMERMANNTROSIENER, I
    BARTHEL, G
    SCHUPPLER, J
    SCHULTEHERMANN, R
    [J]. CARCINOGENESIS, 1984, 5 (04) : 453 - 458
  • [7] CHEN ZY, 1994, CANCER RES, V54, P2622
  • [8] COLUMBANO A, 1985, LAB INVEST, V52, P670
  • [9] COLUMBANO A, 1987, CANCER RES, V47, P5557
  • [10] Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis
    Columbano, A
    Endoh, T
    Denda, A
    Noguchi, O
    Nakae, D
    Hasegawa, K
    LeddaColumbano, GM
    Zedda, AI
    Konishi, Y
    [J]. CARCINOGENESIS, 1996, 17 (03) : 395 - 400